Arkolith/Insider Trading/CNTA/Form 4

Anderson Karen M.

Chief People OfficerCentessa Pharmaceuticals plc (CNTA) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2026Sell(S)10K$28.10$282K62K
Mar 17, 2026Option exercise(M)10K$4.01$40K72K
Mar 16, 2026Option exercise(M)65K$4.01$260K127K
Mar 16, 2026Sell(S)65K$28.21$1.8M62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2026Option exercise(M)10K—$075K
Mar 16, 2026Option exercise(M)65K—$085K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000291) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML